BGDO | Belgian Group of Digestive Oncology

  • Plein écran
  • Ecran large
  • Ecran étroit
  • Increase font size
  • Default font size
  • Decrease font size


E-mail Print PDF

Randomized crossover trial to assess the effects and quality of life in patients with locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel: QOLINPAC

Eudract number 2013-004101-75

Submission planned: Q1 2014

Start inclusion: Q1 204

End of inclusion: Q1 2015